Company Registration No. 8024128 (England and Wales)
Biological Communications Limited
Unaudited accounts
for the year ended 30 April 2024
Biological Communications Limited
Unaudited accounts
Contents
Biological Communications Limited
Company Information
for the year ended 30 April 2024
Director
Mr. Timothy J. Ryder
Company Number
8024128 (England and Wales)
Registered Office
12 Breakspeare
94 College Road
Dulwich, London.
SE21 7NB
Accountants
Ashley & Co. Chartered Certified Accountants
38 Wey House
15 Church Street
Weybridge
Surrey
KT13 8NA
Biological Communications Limited
Statement of financial position
as at 30 April 2024
Cash at bank and in hand
122,017
151,285
Creditors: amounts falling due within one year
(15,446)
(19,641)
Net current assets
135,568
158,076
Net assets
135,743
158,288
Called up share capital
1
1
Profit and loss account
135,742
158,287
Shareholders' funds
135,743
158,288
For the year ending 30 April 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 1 September 2024 and were signed on its behalf by
Mr. Timothy J. Ryder
Director
Company Registration No. 8024128
Biological Communications Limited
Notes to the Accounts
for the year ended 30 April 2024
Biological Communications Limited is a private company, limited by shares, registered in England and Wales, registration number 8024128. The registered office is 12 Breakspeare, 94 College Road, Dulwich, London., SE21 7NB.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
The activity of the company is that of a medical communications consultancy.
Turnover represents the value, net of VAT and discounts, of goods provided to customers and work carried out in respect of services provided to customers.
Tangible fixed assets policy
Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Plant & machinery
Straight Line 15%
4
Tangible fixed assets
Plant & machinery
Biological Communications Limited
Notes to the Accounts
for the year ended 30 April 2024
Amounts falling due within one year
Trade debtors
19,122
16,524
6
Creditors: amounts falling due within one year
2024
2023
Taxes and social security
15,446
19,641
Allotted, called up and fully paid:
1 Ordinary shares of £1 each
1
1
Brought
Forward
Advance/
credit
Repaid
Carried
Forward
Amount due by the director to the company
9,908
9,528
9,908
9,528
Please note the amount includes advances on expenses to the director, which are included in 'other debtors'.
9
Average number of employees
During the year the average number of employees was 1 (2023: 1).